Doctors Note Logo

Published on: 7/21/2026

How does enobosarm compare to placebo for lean mass preservation?

Enobosarm, a selective androgen receptor modulator (SARM), has demonstrated in clinical trials the ability to preserve lean body muscle mass more effectively than a placebo. Studies show participants taking enobosarm experienced measurable improvements in muscle retention, making it a subject of ongoing research for conditions involving muscle wasting, such as cancer cachexia and age-related sarcopenia.

If you're experiencing unexplained muscle loss, fatigue, or weakness, understanding the underlying cause is the critical first step. Symptoms like these can stem from a wide range of conditions—some benign, others requiring prompt medical attention. Rather than guessing or delaying care, take a free, instant, online symptom check to get personalized insights based on your specific symptoms. It takes just a few minutes, requires no signup, and can help you confidently decide your next steps—whether that's monitoring at home or seeing a doctor.

Reviewed for medical accuracy: 07/20/2026

answer background

Explanation

Enobosarm is a type of drug known as a Selective Androgen Receptor Modulator (SARM). In a study involving enobosarm, participants who took the drug showed better preservation of lean body mass compared to those who took a placebo.

Key Points:

  • Study Design: The study was a double-blind, randomized controlled trial. This means neither the participants nor the researchers knew who was receiving enobosarm or the placebo, which helps ensure unbiased results.
  • Results: Participants taking enobosarm maintained more muscle mass than those on the placebo.

Why It Matters:

  • Muscle Preservation: Keeping muscle mass is important for overall health, especially in conditions that cause muscle wasting.
  • Potential Benefits: Enobosarm could be beneficial for people who need to maintain muscle mass due to illness or aging.

If you're experiencing unexplained muscle loss or weakness, it's important to identify the underlying cause. Try Ubie's free AI-powered symptom checker to help understand what might be affecting your muscle health.

(References)

  • Dobs AS, Boccia RV, Croot CC, Gabrail NY, Dalton JT, Hancock ML, et al. (2013). a double-blind, randomised controlled phase 2 trial. The Lancet. Oncology, 23499390.

  • Crawford J, Prado CM, Johnston MA, Gralla RJ, Taylor RP, Hancock ML, & Dalton JT. (2016). Study Design and Rationale for the Phase 3 Clinical .... Current oncology reports, 27138015.

  • Neil D, Clark RV, Magee M, Billiard J, Chan A, Xue Z, & Russell A. (2018). GSK2881078, a SARM, Produces Dose-Dependent .... The Journal of clinical endocrinology and metabolism, 29982690.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.